Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Hazel Maridith Barlahan Biag

Datos Biográficos

ID7970484
NOMBREHazel Maridith Barlahan Biag
NOMBRESHazel Maridith Barlahan
APELLIDOBiag
FIRMABIAG H M B
AFILIACIONESUniversity of California, Davis
ORCID0000-0003-1786-5847
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2021
ÍNDICE H0
  • EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome

    Open Access•Mélodie Proteau-Lemieux, Inga Sophia Knoth et al.•ARTICLE•Frontiers in Psychiatry•2021

    Introduction: Fragile X syndrome (FXS) is a genetic disorder caused by a mutation of the fragile X mental retardation 1 gene ( FMR1 ). FXS is associated with neurophysiological abnormalities, including cortical hyperexcitability. Alterations in electroencephalogram (EEG) resting-state power spectral density (PSD) are well-defined in FXS and were found to be linked to neurodevelopmental delays. Whether non-linear dynamics of the brain signal are a…

  • A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder

    Open Access•Laura A Potter, Danielle A Scholze et al.•ARTICLE•Frontiers in Psychiatry•2019

    Objective: Selective serotonin reuptake inhibitors like sertraline have been shown in observational studies and anecdotal reports to improve language development in young children with fragile X syndrome (FXS). A previous controlled trial of sertraline in young children with FXS found significant improvement in expressive language development as measured by the Mullen Scales of Early Learning (MSEL) among those with comorbid autism spectrum disor…

Sin obras prominentes en esta página.

  • A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder

    Open Access•Laura A Potter, Danielle A Scholze et al.•ARTICLE•Frontiers in Psychiatry•2019

    Objective: Selective serotonin reuptake inhibitors like sertraline have been shown in observational studies and anecdotal reports to improve language development in young children with fragile X syndrome (FXS). A previous controlled trial of sertraline in young children with FXS found significant improvement in expressive language development as measured by the Mullen Scales of Early Learning (MSEL) among those with comorbid autism spectrum disor…

  • EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome

    Open Access•Mélodie Proteau-Lemieux, Inga Sophia Knoth et al.•ARTICLE•Frontiers in Psychiatry•2021

    Introduction: Fragile X syndrome (FXS) is a genetic disorder caused by a mutation of the fragile X mental retardation 1 gene ( FMR1 ). FXS is associated with neurophysiological abnormalities, including cortical hyperexcitability. Alterations in electroencephalogram (EEG) resting-state power spectral density (PSD) are well-defined in FXS and were found to be linked to neurodevelopmental delays. Whether non-linear dynamics of the brain signal are a…

Autism Spectrum Disorder Research (2 obras) · Genetics and Neurodevelopmental Disorders (2 obras) · Medicine (2 obras) · Psychiatry (2 obras) · Psychology (2 obras) · Advanced battery technologies research (1 obras) · Adverse effect (1 obras) · Antidepressant (1 obras) · Anxiety (1 obras) · Audiology (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae